84469 - Gastroenterology

Academic Year 2022/2023

  • Moduli: Luigi Ricciardiello (Modulo 1) Leonardo Henry Umberto Eusebi (Modulo 2)
  • Teaching Mode: Traditional lectures (Modulo 1) Traditional lectures (Modulo 2)
  • Campus: Bologna
  • Corso: Single cycle degree programme (LMCU) in Medicine and Surgery (cod. 9210)

Learning outcomes

Describe the clinical manifestations, etiology, epidemiology, risk factors, natural history, diagnosis, staging, prognostic indicators and management of the major gastrointestinal diseases, as well as hepatobiliary and pancreatic disorders, with emphasis on those most commonly encountered in the clinical practice. Identify the major diagnostic and therapeutic options (including nutritional approaches) for each encountered clinical scenario, and discuss their benefits and limitations. Summarize decision-making algorithms for a correct differential diagnosis, prognosis, and treatment choice. Present and critically analyze clinical cases, discuss the differential diagnosis, and formulate appropriate diagnostic and therapeutic strategies for each case (Problem-Based Learning).

Course contents

Portal Hypertension/Liver cirrhosis

Colorectal cancer/Hereditary GI cancer syndromes/colon cancer screening

Viral hepatitis

Inflammatory Bowel Disease

Gallstones

Celiac disease

Hepatocellular carcinoma

Jaundice/cholestatic disease/ CSP

Diverticular disease/Irritable Bowel Syndrome

Non alcoholic fatty liver disease

Barrett’s esophagus/Gastroesophageal reflux disease/ Esophageal cancer

Gastritis/H. pylori infection /Gastric Cancer

Pancreatitis

Achalasia/ esophageal motor diseases

Peptic ulcer disease/GI bleeding/ gastroesophaeal varices

Readings/Bibliography

Digestive Diseases. 2022-2025 Edition. UNIGASTRO

Sleisenger and Fordtran's Gastrointestinal and Liver Disease

Teaching methods

Class presentations unless otherwise stated by current provisions.

Attendance to learning activities is mandatory; the minimum attendance requirement to be admitted to the final exam is 60% of lessons.

Assessment methods

The final exam will be an oral assessment to verify the achievement of objectives (critical thinking, knowledge of topics) within the integrated course of Abdominal Diseases (IC).

Graduation of the final grade

Insufficient: lack of preparation. Serious and repeated conceptual errors.

18-19: knowledge of the basic concepts without serious gaps. Exposition of concepts and language as a whole acceptable.

20-24: knowledge of the basic concepts without gaps. Ability to analyze and link in partial autonomy. Exposure of discrete concepts and language.

25-29: preparation of good or very good level or even excellent preparation but with inaccuracies in the presentation that compromise the achievement of full marks. Ability to analyze and link independently. Exposure of concepts in the right succession and mastery of the language.

30-30L: full preparation, consolidated and without inaccuracies on the topics covered in the course. Ability to promptly frame the topic. Ability to analyze and connect independently. Concepts in the right succession and full command of the specific language.

Final Grades:

To pass the exam, students will need to reach at least the pass-mark (18/30) in all modules of the I.C. (Abdominal Pathology, Abdominal Radiology, Abdominal Surgery, Gastroenterology, Neprhology, Urology); the final grade will be the marks weighted average. Cum laude will be considered when obtained in at least one of the modules with a full score (30/30) in the others. The student will be able to accept or decline the final grades. If a student did not pass any module, he/she would be able to sustain again only the exam of the failed modules (maintaining the grades obtained in the others), as long as this occurred in the following exam session.

 

Office hours

See the website of Luigi Ricciardiello

See the website of Leonardo Henry Umberto Eusebi

SDGs

Good health and well-being

This teaching activity contributes to the achievement of the Sustainable Development Goals of the UN 2030 Agenda.